Your browser doesn't support javascript.
loading
Rational design of a new antibiotic class for drug-resistant infections.
Durand-Reville, Thomas F; Miller, Alita A; O'Donnell, John P; Wu, Xiaoyun; Sylvester, Mark A; Guler, Satenig; Iyer, Ramkumar; Shapiro, Adam B; Carter, Nicole M; Velez-Vega, Camilo; Moussa, Samir H; McLeod, Sarah M; Chen, April; Tanudra, Angela M; Zhang, Jing; Comita-Prevoir, Janelle; Romero, Jan A; Huynh, Hoan; Ferguson, Andrew D; Horanyi, Peter S; Mayclin, Stephen J; Heine, Henry S; Drusano, George L; Cummings, Jason E; Slayden, Richard A; Tommasi, Ruben A.
  • Durand-Reville TF; Entasis Therapeutics, Waltham, MA, USA.
  • Miller AA; Entasis Therapeutics, Waltham, MA, USA.
  • O'Donnell JP; Entasis Therapeutics, Waltham, MA, USA.
  • Wu X; Novartis Institute for Biomedical Research, Cambridge, MA, USA.
  • Sylvester MA; Entasis Therapeutics, Waltham, MA, USA.
  • Guler S; Entasis Therapeutics, Waltham, MA, USA.
  • Iyer R; EMD Serono, Billerica, MA, USA.
  • Shapiro AB; Entasis Therapeutics, Waltham, MA, USA.
  • Carter NM; Entasis Therapeutics, Waltham, MA, USA.
  • Velez-Vega C; Entasis Therapeutics, Waltham, MA, USA.
  • Moussa SH; Entasis Therapeutics, Waltham, MA, USA.
  • McLeod SM; Novartis Institute for Biomedical Research, Cambridge, MA, USA.
  • Chen A; Entasis Therapeutics, Waltham, MA, USA.
  • Tanudra AM; Entasis Therapeutics, Waltham, MA, USA.
  • Zhang J; Entasis Therapeutics, Waltham, MA, USA.
  • Comita-Prevoir J; Entasis Therapeutics, Waltham, MA, USA.
  • Romero JA; Entasis Therapeutics, Waltham, MA, USA.
  • Huynh H; Janssen Pharmaceuticals, Raritan, NJ, USA.
  • Ferguson AD; Entasis Therapeutics, Waltham, MA, USA.
  • Horanyi PS; Entasis Therapeutics, Waltham, MA, USA.
  • Mayclin SJ; Pfizer, Cambridge, MA, USA.
  • Heine HS; Alkermes, Waltham, MA, USA.
  • Drusano GL; Takeda, Cambridge, MA, USA.
  • Cummings JE; UCB Boston, Bedford, MA, USA.
  • Slayden RA; UCB Boston, Bedford, MA, USA.
  • Tommasi RA; Institute for Therapeutic Innovation, Orlando, FL, USA.
Nature ; 597(7878): 698-702, 2021 09.
Article en En | MEDLINE | ID: mdl-34526714

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Farmacorresistencia Bacteriana Múltiple / Bacterias Gramnegativas / Antibacterianos Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Farmacorresistencia Bacteriana Múltiple / Bacterias Gramnegativas / Antibacterianos Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article